Showing results (551-560 of 3,697) with videos related to
Sort By:
Pageof 370
International Journal of Clinical Oncology|August 16, 2008
Long-term outcomes of peripheral arm ports implanted in patients with colorectal cancerJunichiro Kawamura, Satoshi Nagayama, Akinari Nomura, et al.International Journal of Clinical Oncology|October 12, 2007
Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumorsYukinori Matsuo, Yasushi Nagata, Takashi Mizowaki, et al.International Journal of Clinical Oncology|February 20, 2009
Current status and perspectives of brachytherapy for prostate cancerYasuo YoshiokaInternational Journal of Clinical Oncology|February 20, 2009
Interactive-plan technique conquers the disadvantages of volume-reducing hormone therapy in 125I permanent implantation for localized prostate cancerHiromichi Ishiyama, Takefumi Satoh, Masashi Kitano, et al.International Journal of Clinical Oncology|February 20, 2009
Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancerTsuneo Shimokawa, Masahiko Shibuya, Kazuhiro Kitamura, et al.International Journal of Clinical Oncology|October 6, 2022
Biweekly TAS-102 and bevacizumab as third-line chemotherapy for advanced or recurrent colorectal cancer: a phase II, multicenter, clinical trial (TAS-CC4 study)Hiroshi Matsuoka, Takeshi Yamada, Ryo Ohta, et al.International Journal of Clinical Oncology|November 29, 2023
Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1Yoshinori Kikuchi, Hideaki Shimada, Yutaka Hatanaka, et al.International Journal of Clinical Oncology|January 9, 2024
Impact of prostate position-based image-guidance in intensity-modulated radiation therapy for localized prostate cancerRihito Aizawa, Haruo Inokuchi, Itaru Ikeda, et al.International Journal of Clinical Oncology|January 16, 2024
Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902)Tomono Kawase, Hiroshi Imamura, Ryohei Kawabata, et al.International Journal of Clinical Oncology|January 6, 2024
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencingKazushige Wakuda, Meiko Morita, Motoki Sekikawa, et al.Pageof 370